By Dean Seal
Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer.
The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of corporate development.
He succeeds Brian Di Donato, who told the company over the summer he would step down by the end of the year to take a role as chief executive at an early-stage biotech firm based in San Diego.
Coy was previously the head of transactions and mergers and acquisitions at Eli Lilly. He has served as non-executive director of Immunocore since September 2019.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 02, 2025 07:34 ET (12:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。